Heberprot-P: 10 Years in the Market, 65000 Patients Benefited in Cuba

Havana, May 10 (Prensa Latina) After almost ten years in the market, the Cuban drug Heberprot-P, the only medicine of its kind effective against diabetic foot ulcers, has benefited more than 65,000 patients in the island, it was reported today.

The drug, developed by the Center for Genetic Engineering and Biotechnology (CIGB), has managed to cure a quarter of a million people in the world, after being registered in more than 20 nations, according to the newspaper Granma.

Heberprot-P, which accelerates the healing of injuries and reduces the risk of amputation of lower limbs in almost 80 percent of cases, received a Gold Medal awarded by the World Intellectual Property Organization.

This entry was posted in Healthcare. Bookmark the permalink.